Malignant pleural effision
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: The patients who underwent talc slurry-based pleurodesis for malignant pleural effusion between April 2015 and December 2024.
Exclusion criteria
Exclusion criteria: Patients were excluded if they: (1) had previously undergone chemical pleurodesis on the ipsilateral thorax; (2) underwent prophylactic pleurodesis (it means they were asymptomatic and had pleural fluid confined below the dome of the diaphragm); (3) had a radiologically significant (>25%) non-expandable lung; (4) did not undergo lateral chest X-ray assessment, and therefore the chest tube position was unknown; (5) developed empyema during the treatment; (6) underwent repeat pleurodesis before the chest tube removal; (7) did not undergo any radiological assessment beyond 1 week after pleurodesis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The success rate of pleurodesis | — |
Countries
Japan
Contacts
Hyogo Cancer Center Division of Chest Surgery